About the RD Fund

RD FUND

The RD (Retinal Degeneration) Fund is a 501(c)(3) not-for-profit subsidiary of the Foundation Fighting Blindness. Launched in 2018 as the venture arm of the Foundation and with $122 million under management, the RD Fund focuses on making mission-related investments in companies with projects nearing clinical testing.

The RD Fund aims to deliver life-changing solutions for individuals with retinal degenerative diseases today, while also creating a pipeline of next-generation and novel therapeutic opportunities for tomorrow. The RD Fund is flexible in how it structures investments leveraging equity, debt, royalty, and/or project co-funding. All proceeds of this high-impact philanthropic vehicle are returned back to the Foundation to provide resources to further its mission.

Jacque Duncan

FACTS OF THE FUND

Focuses primarily on companies with programs that are in clinical testing or can be in less than 18 to 24 months

Uses a variety of investment strategies including convertible debt, equity, royalties, and/or project-based co-funding

Deploys a geographically agnostic approach

Targets initial investment allocations ranging between $2 and 5 million with appropriate reserves

Leverages the breadth and depth of the Foundation’s knowledge, global relationships and resources, including the Clinical Consortium, My Retina Tracker® Registry, Scientific Advisory Board, and outside funding from co-investors

Provides returns when a portfolio company exits (company is sold or becomes a publicly traded company) and funds go back to support the Foundation’s mission

Board of Directors

The RD Fund has an independent Board of Directors comprised of prominent investors, business executives, and clinicians to oversee the portfolio of investments, and to ensure alignment with the Foundation’s mission. They are also charged with balancing risk versus return, and to ensure diversification of indications and therapies within the category.

 RD Fund Management

The Fund's experienced team leads the sourcing, diligence, and venture financing of high-impact therapeutic companies advancing treatments and cures for inherited retinal diseases and dry AMD, while generating revenue to further the mission of the Foundation Fighting Blindness.

Foundation Leadership

Key leaders from the Foundation Fighting Blindness provide governance, transactional and scientific strategic guidance to the RD Fund, ensuring its investments align with the mission of delivering transformative breakthroughs.